Two studies presented at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting highlighted MD Anderson’s commitment to holistic patient-centered palliative and supportive care. Both studies examine ways to proactively improve comfort for patients with advanced cancers experiencing uncontrolled cancer-related symptoms.
Neuroleptic rotation for refractory agitation in cancer patients with delirium in the acute palliative...
Updated results from two MD Anderson clinical trials presented at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting indicate...